DocGo shares rise 20.28% intraday after reporting higher-than-expected Q4 revenue, raising 2026 guidance, and exploring strategic alternatives including potential sale or merger.
ByAinvest
Tuesday, Mar 17, 2026 10:31 am ET1min read
DCGO--
DocGo surged 20.28% intraday as the company reported Q4 revenue of $74.9 million, exceeding expectations despite a decline due to winding down immigration projects, raised 2026 revenue guidance to $290M-$310M and narrowed adjusted EBITDA loss to $5M-$10M, and initiated a strategic review exploring potential sale or merger to maximize shareholder value.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet